A Russian Prospective Observational Study of Invasive Fungal Infections in Patients With Acute Leukemia and Hematopoietic Stem Cell Transplantation

Estimate the rate of occurrence of Invasive Fungal Infections (IFIs) in patients with acute leukemia for the first 6 months of chemotherapy (that usually correspond to four courses of chemotherapy), and hematopoietic stem cells transplantation.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Invasive Fungal Infections Agranulocytosis Bacterial Infections and Mycoses Cytopenia Hematologic Diseases Hematologic Neoplasms Hemic and Lymphatic Diseases Infections Leukocyte Disorders Leukopenia Mycoses Neoplasms Neoplasms by Site Neutropenia

Age range

1 year–95 year

Sex eligibility

All sexes

Study type

Observational

Primary location

National Hematological Society

Moscow, 119021, Russia

About this study

This multi-center observational study of IFI in high risk hematological patients, the study will investigate the epidemiology of IFI, describe antifungal strategy, proportion of antifungal prophylaxis, empiric therapy, pre-emptive therapy and targeted therapy in at-risk patients.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Diagnosed with de novo or relapsed AL (AML, ALL)started chemotherapy
All newly allogeneic or autologous transplant recipients during the study period

Treatment and study plan

Primary outcomes

The Rate of Invasive Fungal Infections

Time frame: 6 month

Estimate the rate of IFIs in patients with acute leukemia for the first 6 months of chemotherapy (that usually correspond to four courses of chemotherapy), and hematopoietic stem cells transplantation.

Sponsors and collaborators

Lead sponsor

National Hematological Society, Russia

Other

Registry information

Important dates

Study start: 2012
Primary completion: 2013
Study completion: 2014
First posted: Jan 27, 2012
Registry last updated: Jul 25, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed